HBV therapy (New York Blood Center/Virax)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHBV therapy (New York Blood Center/Virax)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapyVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCytokine receptors agonists
TargetsCytokine receptors
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York Blood Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York Blood CenterPrescient Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A